Annual Meeting

What’s New – Annual Meeting 2019


What’s New?

2019 Annual Meeting

The 2019 Annual Meeting in Cologne, Germany, is just a few short months away and the program continues to come together as we build the meeting around its central theme, HTA beyond 2020: Ready for the New Decade? We have secured our keynote speaker and our plenary sessions have been confirmed. As we get closer to the meeting, stay tuned to our social media channels for additional announcements on webinars, workshops, panels and more.

Pre-conference registration is open until June 9 and spaces are filling quickly. To learn more about Cologne 2019 and to secure a spot, visit

Keynote Address

We are honored to welcome our keynote speaker, Ms. Francesca Colombo. As Head of the Health Division for the Organization for Economic Co-Operation and Development (OECD), Ms. Colombo oversees all major activities and initiatives of the division. These include trends in health spending; measuring of health care outcomes, activities and inputs; health care quality policies; assessing health system efficiency and value for money; long-term care systems and ageing; the economics of public health; pharmaceutical policies, new technologies and big data in health; and health workforce. Ms. Colombo has over 20 years of experience leading international activities on health and health systems. We look forward to hear Ms. Colombo set the tone of the conference during the official Opening Ceremony on June 17 and provide her vision for the future that will stay with the delegates as they participate in the Annual Meeting.



Our captivating plenary sessions take our central theme, “HTA beyond 2020”, and invite a panel of experts to dig deeper into specific themes of the day. This year’s plenary sessions are as follows:

Plenary One, Monday, June 17: HTA Beyond 2020: One Size Fits All? Will International Assessments Improve or Hinder HTA?


Reinhard Busse, Technical University Berlin, Germany

Martin Seychell, DG Health and Food Safety, Malta
Dr. Michelle Mujoomdar, Canadian Agency for Drugs and Technologies in Health (CADTH), Canada
Martin Czech, Deputy Minister, Poland
Dr. Federico Augustovski, Institute for Clinical Effectiveness and Health Policy (IECS), Argentina

In HTA models, the conflict between the consensus that study methodology and HTA evaluations should apply regardless of context and the importance of context-dependent HTA decisions is evident in discussions of the new phase of international HTA collaboration in the EU. Those in favour of joint cross-country assessments based on joint methodologies and requirements argue that such collaborations have potential to increase availability of HTA reports as well as high-quality “real world” data. Opponents, however, are concerned that usefulness for decision-makers at various levels will decrease as the context-specificity is reduced and/or lost.

Plenary Two, Tuesday, June 18: HTA Beyond 2020: The Era Of Digital Health?

Moderator: Professor Jeonghoon Ahn, Ewha Womans University, Korea
Speakers: Dr. Persephone Doupi, THL – National Institute for Health and Welfare, Finland
Dr. Ain Aaviksoo, Guardtime Health, Estonia
Professor Rainer Röhrig, Germany

Digitalization offers many new treatment, diagnostic, and research options as well as tools like smart medical devices, mobile apps, and telehealth. It is not clear yet whether new digital health interventions can and should be assessed by using ‘conventional’ HTA methodology. On the other hand, HTA could directly benefit from digitalization, since the availability of digital data might allow for faster and more detailed research and evaluation. Even HTA processes themselves could be digitized and automated. In summary, there are many opportunities but also challenges for HTA arising from digitalization.

Plenary Three, Wednesday, June 19: HTA Beyond 2020: Need For Smart Capability Building?

Moderator: Dr. Brian O’Rourke, Canadian Agency for Drugs and Technologies in Health (CADTH), Canada
Speakers: Dr. Siw Waffenschmidt, Institute for Quality and Efficiency in Health Care (IQWiG), Germany
Professor Kanchan Mukherjee, Tata Institute of Social Sciences (TISS), India
Dr. Bettina Ryll, Founder, Melanoma Patient Network Europe, Sweden
Mrs. Gesa Pellier, Novartis Pharma AG, Switzerland

As the year 2020 approaches, HTA capabilities may be required to adapt and change to meet evolving stakeholder expectations, data and evidence availability, and biomedical and healthcare service innovations. New capabilities required to produce effective HTA may include, for example, new methodology development, capacity building, and horizon scanning, among others. Given that healthcare systems are already resource constrained, developing additional HTA capabilities will require the HTA community and institutions to implement smart capability building. In summary, critical success factors and best practices will be instrumental to guide smart capability building for HTA beyond 2020.

To learn more about each plenary, visit